Moyamoya vasculopathy with anti-SCL-70 antibodies: A case report and review of the literature.
Journal of Clinical Neuroscience(2018)
摘要
•Anti-SCL-70 antibodies have been associated with moyamoya syndrome.•Either predominant scleroderma or neurologic symptoms may be present.•Treatment involves addressing both neurologic and systemic inflammatory pathologies.
更多查看译文
关键词
Autoimmune,Ischemic stroke,Moyamoya,Scleroderma
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要